Aptose Biosciences Inc. - Common Shares

CUSIP: 03835T200

Q4 2021 13F Holders as of 31 Dec 2021

Holder snapshot 7 signals
Share change
-8,767,301
Put/Call ratio
60%
SEC-reported price per share
$1.35
Number of holders
57
Value change
-$20,800,165
Number of buys
29
Open additional details 1 more signal available
Number of sells
30
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
2,556,332

Security key

03835T200

Report period

Q4 2021

Institutions

57

Top holders

10

Ownership snapshot

Top reported holders of 03835T200 - Aptose Biosciences Inc. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
DRW Securities, LLC
Disclosed value leader
DRW Securities, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F Lead comparable stake: 348% Showing 1-6 of 15 holder rows.

Quick read

DRW Securities, LLC leads the comparable SEC ownership view at 348%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens DRW Securities, LLC's linked filing trail.
Comparable ownership Top 5
DRW Securities, LLC 348%
Nantahala Capital Management, LLC 288%
First Light Asset Management, LLC 161%
683 Capital Management, LLC 122%
Cormorant Asset Management, LP 117%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
DRW Securities, LLC
13F
Company
13F
348%
$19,386,000
8,892,437 shares
30 Sep 2021
Nantahala Capital Management, LLC
13F
Company
13F
288%
$16,035,000
7,355,730 shares
30 Sep 2021
First Light Asset Management, LLC
13F
Company
13F
161%
$9,000,000
4,128,443 shares
30 Sep 2021
683 Capital Management, LLC
13F
Company
13F
122%
$6,786,000
3,112,737 shares
30 Sep 2021
Cormorant Asset Management, LP
13F
Company
13F
117%
$6,540,000
3,000,000 shares
30 Sep 2021
ORBIMED ADVISORS LLC
13F
Company
13F
101%
$5,656,000
2,594,348 shares
30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
57
Shares
31,179,158
Rows available
57
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
63
Q4 2021 holders
57
Holder diff
-6
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .